Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

Executive Summary

Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology firms at the J.P. Morgan meeting.

Advertisement

Related Content

AbbVie’s Business Development, Cancer Plans Not Put Off By Stemcentrx Disappointments
EUSA Sylvant Licence Marks Toehold Into US Rare Disease Market
India Pharma In 2019: Buy, Build And Beware (Patient Power And Amazon)
Bristol/Celgene Made Perfect Sense, But Doesn’t Promise Big M&A Year, EY Says
Immunic of Germany Set For Nasdaq After Merger With Failed Vital Therapies
Sanofi Stumps Up $125m To Access Denali RIPK1 Inhibitors
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC124478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel